ArticleCancer & metabolism2026

VAV2 drives glycolytic reprogramming in esophageal squamous cell carcinoma via EIF3F-mediated MTA1 deubiquitination.

Weiling Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.